Adam Fridhammar
Swedish Institute for Health Economics(SE)
Publications by Year
Research Areas
Diabetes Treatment and Management, Prostate Cancer Diagnosis and Treatment, Diabetes Management and Research, Health Systems, Economic Evaluations, Quality of Life, Prostate Cancer Treatment and Research
Most-Cited Works
- → Introducing PIONEER: a project to harness big data in prostate cancer research(2020)39 cited
- → Comparing the Cohort and Micro-Simulation Modeling Approaches in Cost-Effectiveness Modeling of Type 2 Diabetes Mellitus: A Case Study of the IHE Diabetes Cohort Model and the Economics and Health Outcomes Model of T2DM(2020)27 cited
- → Cost-effectiveness of once-weekly semaglutide versus dulaglutide and lixisenatide in patients with type 2 diabetes with inadequate glycemic control in Sweden(2019)26 cited
- → The implementation of a noninvasive lymph node staging (NILS) preoperative prediction model is cost effective in primary breast cancer(2022)25 cited
- → Cost-effectiveness of liraglutide versus lixisenatide as add-on therapies to basal insulin in type 2 diabetes(2018)17 cited
- → How Well do Polygenic Risk Scores Identify Men at High Risk for Prostate Cancer? Systematic Review and Meta-Analysis(2022)15 cited
- → Intraductal papillary mucinous neoplasms of the pancreas – a cost-effectiveness analysis of management strategies for the branch-duct subtype(2018)15 cited
- → Unanswered questions in prostate cancer — findings of an international multi-stakeholder consensus by the PIONEER consortium(2023)11 cited
- → Long-Term Cost Effectiveness of Oral Semaglutide Versus Empagliflozin and Sitagliptin for the Treatment of Type 2 Diabetes in the Swedish Setting(2022)10 cited
- → MRI-only radiotherapy from an economic perspective: Can new techniques in prostate cancer treatment be cost saving?(2022)9 cited